The Toronto-Dominion Bank
TD
Bank of Montreal
BMO
Royal Bank of Canada
RY
Bank of Nova Scotia
BNS
Canadian Imperial Bank of Commerce
CM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 11.27%-162.21K | -13.58%-171.43K | -844.42%-150.97K | -203.32%-534.83K | -564.10%-185.09K | -956.70%-182.82K | -150.94K | -15.99K | -23.95%-176.33K | -27.87K |
Net income from continuing operations | -28.44%-50.88K | 73.00%-30.56K | -100.24%-130.66K | 8.26%-237.5K | 85.57%-19.45K | -1,837.31%-39.62K | ---113.18K | ---65.25K | 23.97%-258.88K | ---134.83K |
Operating gains losses | 210.75%14.69K | -167.46%-8.73K | -4,264.13%-19.16K | 150.16%17.65K | 161.23%17.52K | 60.67%-13.27K | --12.94K | --460 | -542.07%-35.19K | --6.71K |
Depreciation and amortization | 34.35%176 | 12.10%139 | 107.46%139 | 27.25%481 | 69.15%159 | 37.89%131 | --124 | --67 | 472.73%378 | --94 |
Asset impairment expenditure | --17.54K | ---- | ---- | 859.99%34.07K | --34.07K | --0 | ---- | ---- | --3.55K | ---- |
Remuneration paid in stock | --191.09K | ---- | ---- | 22.39%37.31K | --0 | --0 | ---- | ---- | -81.52%30.48K | --30.48K |
Other non cashItems | ---268.57K | ---119.5K | ---15.58K | ---260.65K | ---175.19K | ---- | ---- | ---- | ---- | ---- |
Change In working capital | -48.54%-66.25K | 83.22%-14.78K | -70.68%14.29K | -251.42%-126.19K | -163.81%-42.2K | -342.70%-44.6K | ---88.13K | --48.74K | 115.37%83.34K | --66.13K |
-Change in receivables | -185.69%-32.15K | -1,899.51%-16.2K | 2,028.20%37.41K | -819.11%-34.15K | -9.80%-20.14K | -625.60%-11.25K | ---810 | ---1.94K | 54.43%-3.72K | ---18.34K |
-Change in prepaid assets | -2,402.22%-23.65K | -122.78%-5.79K | -553.84%-12.24K | -698.99%-16.64K | -318.01%-15.79K | -110.70%-945 | ---2.6K | --2.7K | -72.21%-2.08K | --7.24K |
-Change in payables and accrued expense | 67.73%-10.46K | 108.50%7.2K | -122.67%-10.88K | -184.60%-75.41K | -108.11%-6.27K | -392.07%-32.41K | ---84.72K | --47.98K | 85.48%89.13K | --77.23K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 11.27%-162.21K | -13.58%-171.43K | -844.42%-150.97K | -203.32%-534.83K | -564.10%-185.09K | -956.70%-182.82K | ---150.94K | ---15.99K | -23.95%-176.33K | ---27.87K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -147.49%-610.06K | -34.99%-369.9K | -13.62%-82.27K | -162.52%-1.17M | -354.21%-574.54K | -37.05%-246.5K | -274.02K | -72.4K | -7.42%-444.72K | -126.49K |
Capital expenditure reported | -145.24%-608.56K | -145.75%-369.9K | -13.62%-82.27K | -135.12%-1.05M | -354.21%-574.54K | -37.97%-248.15K | ---150.52K | ---72.4K | -7.76%-444.72K | ---126.49K |
Net PPE purchase and sale | -190.80%-1.5K | ---- | ---- | ---1.85K | --0 | --1.65K | ---- | ---- | --0 | --0 |
Net other investing changes | ---- | ---- | ---- | ---120K | --0 | --0 | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -147.49%-610.06K | -34.99%-369.9K | -13.62%-82.27K | -162.52%-1.17M | -354.21%-574.54K | -37.05%-246.5K | ---274.02K | ---72.4K | -7.42%-444.72K | ---126.49K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 43.22%2.53M | 0 | 1,906.75%2.4M | 0 | 9.41K | 1.76M | 630.05K | -90.05%119.72K | -278 |
Net common stock issuance | --0 | 35.32%2.56M | --0 | 1,933.71%2.44M | --0 | --9.59K | --1.89M | --539K | -89.52%120K | --0 |
Net other financing activities | --0 | ---- | ---- | -13,544.96%-37.93K | --0 | ---179 | ---128.81K | --91.05K | -100.47%-278 | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | 43.22%2.53M | --0 | 1,906.75%2.4M | --0 | --9.41K | --1.76M | --630.05K | -90.05%119.72K | ---278 |
Net cash flow | ||||||||||
Beginning cash position | 26.34%2.74M | -8.96%756.8K | 241.63%989.38K | -63.26%289.61K | 294.41%1.75M | 239.21%2.17M | --831.26K | --289.61K | 463.88%788.32K | --443.6K |
Current changes in cash | -83.91%-772.27K | 48.25%1.98M | -143.06%-233.23K | 239.68%700.23K | -391.22%-759.63K | -112.97%-419.91K | --1.34M | --541.66K | -177.41%-501.32K | ---154.64K |
Effect of exchange rate changes | -210.26%-333 | 143.87%68 | 5,963.64%645 | -117.25%-451 | -190.31%-587 | -76.26%302 | ---155 | ---11 | 180.77%2.61K | --650 |
End cash Position | 12.48%1.97M | 26.34%2.74M | -8.96%756.8K | 241.63%989.38K | 241.63%989.38K | 294.41%1.75M | --2.17M | --831.26K | -63.26%289.61K | --289.61K |
Free cash from | -79.88%-772.27K | -77.51%-541.33K | -163.87%-233.23K | -154.78%-1.58M | -392.11%-759.63K | -117.75%-429.32K | ---304.96K | ---88.39K | -11.65%-621.05K | ---154.36K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.